Financial Sense Advisors Inc. reduced its holdings in shares of iShares Biotechnology ETF ( NASDAQ:IBB – Free Report ) by 41.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,640 shares of the financial services provider's stock after selling 1,180 shares during the quarter. Financial Sense Advisors Inc.'s holdings in iShares Biotechnology ETF were worth $212,000 as of its most recent SEC filing. Other institutional investors and hedge funds also recently made changes to their positions in the company.

https://www.dailypolitical.com/2023/07/08/financial-sense-advisors-inc-trims-holdings-in-ishares-biotechnology-etf-nasdaqibb.html

#dailypolitical